Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 05 2022
Historique:
received: 08 04 2021
accepted: 28 04 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 20 5 2022
Statut: epublish

Résumé

Soluble aggregates of the microtubule-associated protein tau have been challenging to assemble and characterize, despite their important role in the development of tauopathies. We found that sequential hyperphosphorylation by protein kinase A in conjugation with either glycogen synthase kinase 3β or stress activated protein kinase 4 enabled recombinant wild-type tau of isoform 0N4R to spontaneously polymerize into small amorphous aggregates in vitro. We employed tandem mass spectrometry to determine the phosphorylation sites, high-resolution native mass spectrometry to measure the degree of phosphorylation, and super-resolution microscopy and electron microscopy to characterize the morphology of aggregates formed. Functionally, compared with the unmodified aggregates, which require heparin induction to assemble, these self-assembled hyperphosphorylated tau aggregates more efficiently disrupt membrane bilayers and induce Toll-like receptor 4-dependent responses in human macrophages. Together, our results demonstrate that hyperphosphorylated tau aggregates are potentially damaging to cells, suggesting a mechanism for how hyperphosphorylation could drive neuroinflammation in tauopathies.

Identifiants

pubmed: 35577786
doi: 10.1038/s41467-022-30461-x
pii: 10.1038/s41467-022-30461-x
pmc: PMC9110413
doi:

Substances chimiques

Protein Isoforms 0
TLR4 protein, human 0
Toll-Like Receptor 4 0
tau Proteins 0
Heparin 9005-49-6
Glycogen Synthase Kinase 3 beta EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2692

Subventions

Organisme : Wellcome Trust
ID : 107032AIA
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 108045/Z/15/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Brain. 2020 Mar 1;143(3):1010-1026
pubmed: 32179883
EMBO J. 2018 Apr 3;37(7):
pubmed: 29472250
Comput Struct Biotechnol J. 2014 Oct 02;12(20-21):7-13
pubmed: 25505502
J Neurochem. 2013 Sep;126(5):662-72
pubmed: 23586526
Brain Res Mol Brain Res. 2005 Jul 29;138(1):84-93
pubmed: 15913837
J Biol Chem. 2008 Nov 14;283(46):32066-76
pubmed: 18725412
Mol Pharmacol. 2006 Apr;69(4):1288-95
pubmed: 16373689
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):23-8
pubmed: 14525794
Br J Pharmacol. 2009 Aug;157(7):1250-62
pubmed: 19563534
Mol Cell Biol. 2000 Dec;20(24):9356-63
pubmed: 11094086
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Neurochem Int. 2008 Mar-Apr;52(4-5):621-33
pubmed: 18035450
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6923-8
pubmed: 11381127
Mol Cell Biochem. 1994 Nov 23;140(2):119-25
pubmed: 7898484
Annu Rev Neurosci. 2001;24:1121-59
pubmed: 11520930
ACS Chem Neurosci. 2018 Jun 20;9(6):1276-1282
pubmed: 29590529
Cell Death Dis. 2018 Jan 25;9(2):120
pubmed: 29371603
J Am Chem Soc. 2009 Dec 2;131(47):17482-9
pubmed: 19888725
Biochemistry. 2012 Mar 27;51(12):2539-50
pubmed: 22401494
BMC Neurosci. 2015 Sep 07;16:57
pubmed: 26346361
Immunity. 2018 Jan 16;48(1):59-74.e5
pubmed: 29343440
Cell Rep. 2017 Dec 12;21(11):3310-3316
pubmed: 29241555
J Biol Chem. 2007 Aug 10;282(32):23645-54
pubmed: 17562708
Trends Mol Med. 2009 Mar;15(3):112-9
pubmed: 19246243
Neurosci Res. 2006 Mar;54(3):197-201
pubmed: 16406150
Brain Res. 1993 Nov 19;628(1-2):77-84
pubmed: 8313173
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4125-4130
pubmed: 32029593
J Neurochem. 1996 Sep;67(3):1183-90
pubmed: 8752125
J Biol Chem. 2013 Aug 9;288(32):23331-47
pubmed: 23798682
Nat Rev Neurosci. 2016 Jan;17(1):5-21
pubmed: 26631930
Mol Med Rep. 2018 Apr;17(4):5484-5491
pubmed: 29393460
Elife. 2019 Feb 05;8:
pubmed: 30720432
J Am Chem Soc. 2011 Oct 12;133(40):15842-5
pubmed: 21910444
Front Neurol. 2013 Aug 15;4:112
pubmed: 23966973
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12540-12549
pubmed: 31152136
J Biol Chem. 1993 Nov 15;268(32):24374-84
pubmed: 8226987
Anal Chem. 2015 Apr 21;87(8):4370-6
pubmed: 25799115
Angew Chem Int Ed Engl. 2017 Jun 26;56(27):7750-7754
pubmed: 28474754
Biochemistry. 2005 Jan 11;44(1):149-56
pubmed: 15628855
Nat Methods. 2013 Jun;10(6):557-62
pubmed: 23624665
FEBS Lett. 2006 Nov 13;580(26):6269-74
pubmed: 17078951
Am J Pathol. 2006 May;168(5):1598-607
pubmed: 16651626
J Mol Neurosci. 2011 Nov;45(3):438-44
pubmed: 21638071
Cell Mol Immunol. 2017 Feb;14(2):180-191
pubmed: 26277896
Neurobiol Aging. 2003 Oct;24(6):767-76
pubmed: 12927759
Biochemistry. 2003 Dec 30;42(51):15009-17
pubmed: 14690409
BMC Pulm Med. 2017 Dec 12;17(1):194
pubmed: 29233104
Chem Sci. 2020 Feb 21;11(18):4578-4583
pubmed: 34122915
Brain Res Brain Res Rev. 2000 Aug;33(1):95-130
pubmed: 10967355
Can J Physiol Pharmacol. 2016 Feb;94(2):140-146
pubmed: 26544923
Proc Natl Acad Sci U S A. 1986 Jun;83(11):4044-8
pubmed: 2424016
Autophagy. 2009 Aug;5(6):887-9
pubmed: 19550142
J Am Chem Soc. 2018 Nov 7;140(44):14789-14798
pubmed: 30351023
Eur J Neurosci. 2007 May;25(10):3020-9
pubmed: 17561815
Circ Res. 2009 Jan 30;104(2):210-8, 21p following 218
pubmed: 19096031
ACS Chem Biol. 2018 Mar 16;13(3):636-646
pubmed: 29300447
ACS Chem Biol. 2019 Jun 21;14(6):1363-1379
pubmed: 31046227
J Neural Transm (Vienna). 2005 Jun;112(6):813-38
pubmed: 15517432
Chembiochem. 2018 Oct 4;19(19):2033-2038
pubmed: 30051958
J Biol Chem. 2013 Jan 18;288(3):1856-70
pubmed: 23188818
J Biol Chem. 2014 Dec 5;289(49):34389-407
pubmed: 25339173
J Neurochem. 2006 Oct;99(1):154-64
pubmed: 16987243
ACS Chem Neurosci. 2021 May 5;12(9):1621-1631
pubmed: 33877805
Cell. 2020 Dec 10;183(6):1699-1713.e13
pubmed: 33188775
Nat Commun. 2019 Apr 4;10(1):1541
pubmed: 30948723
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5
pubmed: 15867159
Alzheimers Res Ther. 2015 Apr 15;7(1):41
pubmed: 25878730
J Neurosci Res. 2001 Oct 15;66(2):214-20
pubmed: 11592116
Biochemistry. 2006 Feb 21;45(7):2283-93
pubmed: 16475817
Biomolecules. 2016 Jan 06;6(1):6
pubmed: 26751493
Mol Pharmacol. 2011 Jan;79(1):34-41
pubmed: 20881006
Biochemistry. 2015 Dec 22;54(50):7320-5
pubmed: 26575330
Commun Biol. 2020 Feb 18;3(1):79
pubmed: 32071389
Mol Neurodegener. 2007 Jun 28;2:12
pubmed: 17598919
Nature. 1996 Oct 10;383(6600):550-3
pubmed: 8849730
Angew Chem Int Ed Engl. 2018 Apr 23;57(18):4886-4890
pubmed: 29342318
Brain. 2018 Sep 1;141(9):2740-2754
pubmed: 30052812

Auteurs

Jonathan X Meng (JX)

Department of Chemistry, University of Cambridge, Cambridge, UK.
UK Dementia Research Institute at Cambridge, Cambridge, UK.

Yu Zhang (Y)

Department of Chemistry, University of Cambridge, Cambridge, UK.
Molecular Immunity Unit, Department of Medicine, MRC Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.

Dominik Saman (D)

Department of Chemistry, University of Oxford, Oxford, UK.

Arshad M Haider (AM)

UK Dementia Research Institute at Cambridge, Cambridge, UK.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Suman De (S)

Department of Chemistry, University of Cambridge, Cambridge, UK.
Department of Neuroscience Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.

Jason C Sang (JC)

Department of Chemistry, University of Cambridge, Cambridge, UK.
UK Dementia Research Institute at Cambridge, Cambridge, UK.

Karen Brown (K)

Molecular Immunity Unit, Department of Medicine, MRC Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.

Kun Jiang (K)

Department of Chemistry, University of Cambridge, Cambridge, UK.

Jane Humphrey (J)

Department of Chemistry, University of Cambridge, Cambridge, UK.

Linda Julian (L)

Department of Chemistry, University of Cambridge, Cambridge, UK.
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.

Eric Hidari (E)

UK Dementia Research Institute at Cambridge, Cambridge, UK.

Steven F Lee (SF)

Department of Chemistry, University of Cambridge, Cambridge, UK.

Gabriel Balmus (G)

UK Dementia Research Institute at Cambridge, Cambridge, UK.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

R Andres Floto (RA)

Molecular Immunity Unit, Department of Medicine, MRC Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.

Clare E Bryant (CE)

Medicine and Veterinary Medicine, University of Cambridge, Cambridge, UK.

Justin L P Benesch (JLP)

Department of Chemistry, University of Oxford, Oxford, UK.

Yu Ye (Y)

Department of Chemistry, University of Cambridge, Cambridge, UK.
Department of Brain Sciences, Imperial College London, London, UK.
UK Dementia Research Institute at Imperial College London, London, UK.

David Klenerman (D)

Department of Chemistry, University of Cambridge, Cambridge, UK. dk10012@cam.ac.uk.
UK Dementia Research Institute at Cambridge, Cambridge, UK. dk10012@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH